Latest news
AbCellera to Announce Top-Line Results from the Phase 2 Trial of ABCL635 for the Treatment of Moderate-to-Severe VMS Due to Menopause on Monday, August 10, 2026 - Business WireBusiness Wire · Fri, 07 Aug 2026 20:30:00 GMTHigh-Dose Vitamin D3 Falls Short in Phase 3 Colorectal Cancer Trial - Pharmacy TimesPharmacy Times · Fri, 07 Aug 2026 20:14:33 GMTOral TYK2 Inhibitor Socrodeucitinib Meets Primary Endpoint in Phase 2 Psoriasis Trial - Dermatology TimesDermatology Times · Fri, 07 Aug 2026 16:04:43 GMTEyeWorld Weekly, August 7, 2026 - EyeWorldEyeWorld · Fri, 07 Aug 2026 16:04:01 GMTSuccessful Trials of Fridge-Free Vaccines To Boost Global Distribution - EMJEMJ · Fri, 07 Aug 2026 13:22:36 GMTBioVie stock sinks on Phase IIb Parkinson’s trial data - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:14:16 GMTSemaglutide Showed Promise in MASH Fibrosis Trial - EMJEMJ · Fri, 07 Aug 2026 09:02:12 GMTThe Brain Is the Frontier: Inside the Trial That’s Rewriting the CAR-T Playbook for Glioblastoma - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 07:31:37 GMT